Profound Medical Corp T.PRN

Alternate Symbol(s): PROF

Healthcare Medical Devices

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while protecting the urethra and rectum. TULSA-PRO has the potential to be a flexible technology in customizable prostate ablation, including intermediate stage cancer, localized radio-recurrent cancer, retention and hematuria palliation in locally advanced prostate cancer and the transition zone in large volume benign prostatic hyperplasia. It is also commercializing Sonalleve, which is a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

TSX:PRN - Post by User

Profound Medical Corp > Raymond James

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon Dec 12, 2020 1:00pm

169 Views

Post# 32093541

RE:Raymond James

retiredcf wrote:
10 Dec 2020
Profound Medical Corp. (PRN.T)

Target Set by Raymond James (C$22.97) C$43.00 Strong-Buy

I am assuming, to get some real traction here, we need to start adding locations a little faster - maybe a first in Canada to get Knight buiding in parallel.

From the last conference call, it doesn't look like we're done adding in 2020.

Fingers crossed.

<< Previous

Bullboard Posts

Next >>

Fobi AI could address a market in the trillions: Why it's time to buy